ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag pharma nonprofit clinical trials cancer

Updated July 9
Track COVID-19 Vaccines Advancing Through Clinical Trials
The Scientist | Apr 7, 2020 | 10+ min read
Find the latest updates in this one-stop resource, including efficacy data and side effects of approved shots, as well as progress on new candidates entering human studies.
How the Pharma Industry Pulled Off the Pivot to COVID-19
Diana Kwon | Jul 13, 2020 | 9 min read
The urgent need for tests and therapeutics has brought companies together and pushed researchers to work at breakneck speeds.
The Growth of Iowa Biotech
Jenny Rood | Aug 1, 2016 | 7 min read
The state’s industry draws inspiration from medicine as well as agriculture.
Start It Up
Dan Cossins | Apr 1, 2013 | 8 min read
Young researchers who left the academic path to transform their bright ideas into thriving companies discuss their experiences, and how you can launch your own business.
Supplement: Greater Philadelphia's Big Pharmas
Mike May | Jan 1, 2008 | 5 min read
Greater Philadelphia's Big Pharmas By Mike May A wide range of large pharmaceutical companies make up a strong foundation for life science in the region. RELATED ARTICLES A Region Defined Did You Know? A Rich Life Science Cluster A Robust Support Infrastructure Barbara Schilberg: Champion for the region Bridging the Gap Brenda Gavin: Making a venture capitalist Investment Momentum Building Update Those Resumes Creating Roots Ramping Up Tech Tr
Duke Cardiologist Tapped to Lead FDA
Bob Grant | Sep 17, 2015 | 2 min read
The Obama administration has nominated Robert Califf, a researcher who conducted large clinical trials, as the next person to head the country’s drug approval agency.
The “Me Decade” of Cancer
Sarah Greene | Apr 1, 2011 | 3 min read
Drugs that target specific tumors are harbingers of a new era of genetically informed medicine.
The Me Decade of Cancer
Sarah Greene | Apr 1, 2011 | 3 min read
By Sarah Greene The “Me Decade” of Cancer Drugs that target specific tumors are harbingers of a new era of genetically informed medicine. The old rules involving randomized populations may not provide the best answers. Thirty-five years ago journalist Tom Wolfe anointed the ‘70s in America the Me Decade—critiquing the quest for self-actualization via primal-scream therapy, high colonics, and mysticism. The age of social conscious
Venture Capital, with a Twist
Ted Agres(tagres@the-scientist.com) | Jul 17, 2005 | 5 min read
Jamie Heywood, chief executive of the Amyotrophic Lateral Sclerosis Therapy Development Foundation (ALSTDF), founded the nonprofit biotech company in 1999 after his brother was diagnosed with ALS.
The Little Cell That Could
Megan Scudellari | Jul 1, 2012 | 7 min read
Critics point out that cell therapy has yet to top existing treatments. Biotech companies are setting out to change that—and prove that the technology can revolutionize medicine.

Run a Search

ADVERTISEMENT